Hosted on MSN
Bio-Techne outlines 100 basis points margin expansion for FY26 following Exosome Diagnostics divestiture
Kim Kelderman, CEO, announced "we delivered a solid quarter that was in line with our expectations," highlighting 3% organic revenue growth and robust demand from large pharma for automated proteomic ...
August 24, 2017 - Baltimore, Md. and Boston, Ma., Aug. 24, 2017 (GLOBE NEWSWIRE) -- CareFirst BlueCross BlueShield (CareFirst) and Exosome Diagnostics, Inc. (ExoDx) announced today that they have ...
DUBLIN--(BUSINESS WIRE)--The "Exosome Diagnostics and Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. Initially, exosome particles were considered garbage ...
NEW YORK, Sept. 19, 2013 /PRNewswire/ -- Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation ...
DUBLIN--(BUSINESS WIRE)--The "Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for exosome ...
Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a proof-of-concept study for a novel exosome-based platform that could ...
Exosome Diagnostics, Inc., the developer of a revolutionary liquid biopsy platform that enables non-invasive diagnosis of serious diseases, aiming to reduce or eliminate the need for tissue biopsies, ...
Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer ...
Tests will combine Scorpions® real-time PCR mutation kits with ExosomeDx’ blood-based exosome technology. Exosome Diagnostics and DxS are combining their technologies to develop new blood-based ...
LONDON, March 5, 2026 /PRNewswire/ -- The "Exosome Diagnostic and Therapeutics Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence ...
Dublin, July 07, 2026 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The Exosome Diagnostics ...
Dublin, May 28, 2026 (GLOBE NEWSWIRE) -- The "Tumor Exosome Profiling Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor exosome profiling market has experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results